Table 2 Comparison between the impact of AgNPs and antibiotics on tested bacteria
From: Silver nanoparticles synthesized by probiotic bacteria and antibacterial role in resistant bacteria
The average size of the growth inhibitory zone (mm) | ||||
|---|---|---|---|---|
Proteus vulgaris | Escherichia coli | Staphylococcus aureus | Klebsiella pneumonia | |
Biogenic antibiotics (200 µg/mL) | ||||
Ampicillin | 5 | 0 | 5 | 0 |
Gentamycin | 8 | 7 | 4 | 0 |
Streptomycin | 10 | 9 | 9 | 0 |
Nanosilver concentration (µg/mL) | ||||
10 | 5 | 0 | 0 | 5 |
25 | 5 | 6 | 7 | 6 |
50 | 11 | 13 | 12 | 11 |
100 | 19 | 19 | 18 | 20 |